Off Patent
January 2027

Nucynta

tapentadol hydrochloride

Collegium Pharmaceutical Inc

Tablet (oral) · NDA 022304

Last listed protection ends
January 3, 2027

The FDA lists 2 exclusivities for Nucynta, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    New patient population exclusivity
    FDA code NPP
  2. Pediatric exclusivity
    FDA code PED